NCT07200492

Anti-Redness Clinical Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: ChinaNorm · Industry
• Sex: Female
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This clinical study is a single-center, randomized, split-face, on-site controlled trial conducted at Shanghai China-Norm Quality Technical Service Co., Ltd. The primary objective is to evaluate the efficacy of Eucerin Ultrasensitive Repair Intensive Source Serum in providing instant and long-lasting (24-hour) soothing and repairing effects under induced redness conditions. The design involves recruiting 30 healthy Chinese female subjects aged 18-60 years, who meet stringent inclusion/exclusion criteria, including absence of skin conditions and no recent participation in similar studies. Redness is induced using 50% Glycolic Acid on the entire face and tape stripping on both forearms.

Conditions

• Redness

Interventions

Type	Name	Description
OTHER	Facial serum application	The trained technician will apply the 0.3g-0.4g investigational products on the subject's half face.
OTHER	Forearm serum application	The trained technician will apply the (2mg±0.1mg)/cm² investigational products on the subject's forearm.

Timeline

• Start date: 2024-01-15
• Primary completion: 2024-01-22
• Completion: 2024-01-24
• First posted: 2025-10-01
• Last updated: 2025-10-01

Locations

1 site across 1 country: China